Mucus Relief D Tablet, Film Coated
NDC Package 41250-547-72
Package Information
Mucus Relief D (guaifenesin, pseudoephedrine hcl) tablets is adults and children 12 years of age and older: take 1 tablet every 4 hours, with a full glass of water, while symptoms persist. This formulation utilizes a tablet, film coated delivery system. Marketed by Meijer Distribution Inc, this product is identified by NDC 41250-547 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1090623 - guaiFENesin 400 MG / pseudoephedrine HCl 40 MG Oral Tablet
- RxCUI: 1090623 - guaifenesin 400 MG / pseudoephedrine hydrochloride 40 MG Oral Tablet
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 41250 - Meijer Distribution Inc
- 41250-547 - Mucus Relief D
- 41250-547-72 - 3 BLISTER PACK in 1 CARTON / 9 TABLET, FILM COATED in 1 BLISTER PACK
- 41250-547 - Mucus Relief D
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 41250-547-72 identifies a specific commercial package of 3 blister pack in 1 carton / 9 tablet, film coated in 1 blister pack of Mucus Relief D, a human over the counter drug labeled by Meijer Distribution Inc. This tablet, film coated is formulated for oral use and contains guaifenesin; pseudoephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Meijer Distribution Inc on January 26, 2007. The current certification is valid through December 31, 2026.
How is this Meijer Distribution Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 41250054772. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.